Sun Pharma gets USFDA nod for Flomax's generic version
Press Trust of India / New Delhi Jul 16, 2010, 14:34 IST
Sun Pharmaceutical Industries today said that it has received the US health regulator's nod to market a generic version of Flomax tamsulosin capsules, used for treating enlarged prostate, in the American market.
The company has bagged the Abbreviated New Drug Application approval from the US Food and Drugs Administration (USFDA) for tamsulosin hydrochloride capsules in the strength of 0.4 mg, Sun Pharma said in a statement.